ProPhase Labs, Inc.

ProPhase Labs, Inc.

$0.24
-0.11 (-30.64%)
NASDAQ Capital Market
USD, US
Drug Manufacturers - Specialty & Generic

PRPH Price Chart

Basic
Market Cap$8.38M
Price$0.24
52 Week Range0.22-7.48
Beta-0.10
Margins
Gross Profit Margin-2.22%
Operating Profit Margin-570.59%
Net Profit Margin-788.24%
Valuation (TTM)
P/E Ratio-0.08
Price to Sales Ratio1.48
Price to Book Ratio0.61
PEG Ratio-0.00

Industry

Drug Manufacturers - Specialty & Generic

Sector

Healthcare

Full-Time Employees

113

IPO Date

1994-04-04T00:00:00.000Z

Description

ProPhase Labs, Inc. engages in the research, development, manufacture, distribution, marketing, and sale of over the counter (OTC) consumer healthcare products and dietary supplements in the United States. The company operates in two segments, Diagnostic Services and Consumer Products. It offers a range of OTC dietary supplements, including Legendz XL for male sexual health; and Triple Edge XL, an energy and stamina booster. The company also provides contract manufacturing services, such as product development, pre-commercialization, production, warehousing, and distribution; SARS-CoV-2 (COVID-19) and COVID-19 viral mutation polymerase chain reaction tests through saliva and nasal swab methods; and other respiratory pathogen panel molecular testing services, as well as personal genomics products and services. It serves national chain drug, internet-based, and various regional retailers. The company was formerly known as The Quigley Corporation. ProPhase Labs, Inc. was founded in 1989 and is headquartered in Garden City, New York.

Phone

215 345 0919

Address

711 Stewart Avenue, Garden City, NY, 11530, US

CIK

0000868278